RxMP Therapeutics featured again on BioPub. Dr. Rif Pamukcu CEO and Dr. Mike Davis, former Director of the U.S. Combat Casualty Care Research Program, give shareholders an update on the current raise and outlook for 2024.
RxMP Therapeutics featured on BioPub
Previous
Previous
RxMP Therapeutics Provides Documents for Latest Raise.
Next
Next